Quick Takeaways
- Parag Saxena filed SCHEDULE 13D/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH).
- Disclosed ownership: 2.8%.
- Date of event: 20 Mar 2026.
Parag Saxena - 20 Mar 2026 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH)
- Filing Manager
- Parag Saxena
- Reporting Manager
- Parag Saxena
- Symbol
- RVPH
- Shares outstanding
- 12,974,286 shares
- Disclosed Ownership
- 363,280 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 24 Mar 2026, 16:15:24 UTC
- Date of event
- 20 Mar 2026
- Previous filing
- 22 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Parag Saxena disclosed 2.8% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH) on 20 Mar 2026."
What Changed
- Previous schedule filing date: 22 Dec 2025.
- Current filing was accepted on 24 Mar 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Parag Saxena | 2.8% | 363,280 | 45,047 | 318,233 | /s/ Parag Saxena | Parag Saxena/Individual | 0001015823 |